Effect of rosa canina on non alcoholic fatty liver disaese
Not Applicable
Recruiting
- Conditions
- on alchoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedK76.0
- Registration Number
- IRCT20230903059334N1
- Lead Sponsor
- Khalkhal university of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 116
Inclusion Criteria
All people with non-alcoholic fatty liver disease referring to Internist
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver enzymes. Timepoint: At the beginning of the study and 8 weeks after the start of taking rosa canina supplement. Method of measurement: Pars azmoon liver enzymes kit.;Lipid profile. Timepoint: At the beginning of the study and 8 weeks after the start of taking rosa canina supplement. Method of measurement: Pars Azmoun Cholesterol Quantification Kit.;Fasting blood sugar. Timepoint: At the beginning of the study and 8 weeks after the start of taking rosa canina supplement. Method of measurement: Glucose Quantification Kit Pars Azman.;Body weight. Timepoint: At the beginning of the study and 8 weeks after the start of taking rosa canina supplement. Method of measurement: Seca scale.
- Secondary Outcome Measures
Name Time Method Blood pressure. Timepoint: At the beginning of the study and 8 weeks after the start of taking rosa canina supplement. Method of measurement: Barometer.;Waist circulate. Timepoint: At the beginning of the study and 8 weeks after the start of taking rosa canina supplement. Method of measurement: Measuring tape.;Body fat mass. Timepoint: At the beginning of the study and 8 weeks after the start of taking rosa canina supplement. Method of measurement: Inbody body analyzer.;Body muscle mass. Timepoint: At the beginning of the study and 8 weeks after the start of taking rosa canina supplement. Method of measurement: Inbody body analyzer.